Similar Posts
Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
What is an H-bomb?
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email North Korea claims they successfully tested a “miniaturized” hydrogen bomb. So, what exactly is an H-bomb? 01:23 Thu, Jan 7 20169:00 AM EST Nina Raja
Trader bets gold about to get its shine back
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Bullion bounces back. Can gold shine again? With CNBC’s Seema Mody and the Futures Now traders, Jim Iuorio at the CME and Anthony Grisanti at the NYMEX. 02:08 Thu, Sep 26 20192:27 PM EDT
Bitcoin ETFs will ‘mainstream’ the asset class, says WisdomTree CEO
Jonathan Steinberg, WisdomTree CEO, joins ‘Money Movers’ to discuss spot Bitcoin ETF and the sector outlook.
Neiman Marcus CEO talks pullback in luxury spending over the holidays
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Geoffroy van Raemdonck, Neiman Marcus CEO, joins ‘Closing Bell Overtime’ to talk holiday retail performance, the state of the luxury consumer and more. 04:42 Tue, Jan 9 20245:45 PM EST
A point-of-sale system like Square on steroids
A New York City cowboy boot store may sell classic styles, but it’s been improving its sales by using technology and analytics on the Bindo POS iPad app.
